Skip to content

Clinical trials

Phase 2 Basal Ganglia Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Basal Ganglia Diseases Phase: Phase 2 Clear all

4 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20101
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed2
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bial R&D Investments, S.A.1
Juvantia Pharma Ltd1
Neurologix, Inc.1
Ron Postuma1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Basal Ganglia Diseases4
Movement Disorders4
Parkinson Disease4
Central Nervous System Diseases3
Neurodegenerative Diseases3
Parkinsonian Disorders3
Brain Diseases2
Nervous System Diseases2
Dyskinesias1
Ganglion Cysts1

Trials

Showing 26 to 4 of 4. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.